IN2015DN03862A - - Google Patents
Info
- Publication number
- IN2015DN03862A IN2015DN03862A IN3862DEN2015A IN2015DN03862A IN 2015DN03862 A IN2015DN03862 A IN 2015DN03862A IN 3862DEN2015 A IN3862DEN2015 A IN 3862DEN2015A IN 2015DN03862 A IN2015DN03862 A IN 2015DN03862A
- Authority
- IN
- India
- Prior art keywords
- neuroinflammation
- toddlers
- relates
- nutritional compositions
- infants
- Prior art date
Links
- 241000186012 Bifidobacterium breve Species 0.000 abstract 1
- 208000036110 Neuroinflammatory disease Diseases 0.000 abstract 1
- 230000003542 behavioural effect Effects 0.000 abstract 1
- 230000001149 cognitive effect Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000003959 neuroinflammation Effects 0.000 abstract 1
- 235000016709 nutrition Nutrition 0.000 abstract 1
- 229920001542 oligosaccharide Polymers 0.000 abstract 1
- 150000002482 oligosaccharides Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/733—Fructosans, e.g. inulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/009—Sachets, pouches characterised by the material or function of the envelope
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/519—Breve
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K2035/11—Medicinal preparations comprising living procariotic cells
- A61K2035/115—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pediatric Medicine (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The invention relates to nutritional compositions with Bifidobacterium breve and non- digestible oligosaccharides for use infants or toddlers for use in improving cognitive or behavioral performance or neuroinflammation.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261721833P | 2012-11-02 | 2012-11-02 | |
EP12191171 | 2012-11-02 | ||
PCT/NL2013/050785 WO2014070016A2 (en) | 2012-11-02 | 2013-11-04 | Synbiotics combination for brain improvement |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2015DN03862A true IN2015DN03862A (en) | 2015-10-02 |
Family
ID=47148641
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN3862DEN2015 IN2015DN03862A (en) | 2012-11-02 | 2013-11-04 |
Country Status (12)
Country | Link |
---|---|
US (2) | US9974816B2 (en) |
EP (2) | EP3936134A1 (en) |
CN (2) | CN107853705A (en) |
AU (1) | AU2013338705B2 (en) |
BR (1) | BR112015009579B1 (en) |
ES (1) | ES2884223T3 (en) |
IN (1) | IN2015DN03862A (en) |
MY (1) | MY173726A (en) |
PH (1) | PH12015500904B1 (en) |
PL (1) | PL2914136T3 (en) |
RU (1) | RU2630905C2 (en) |
WO (1) | WO2014070016A2 (en) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015160234A1 (en) * | 2014-04-17 | 2015-10-22 | N.V. Nutricia | Composition for brain improvement |
US20150305359A1 (en) * | 2014-04-24 | 2015-10-29 | Mead Johnson Nutrition Company | Nutritional compositions directed to subjects having cow's milk protein allergies |
WO2016013928A1 (en) * | 2014-07-24 | 2016-01-28 | N.V. Nutricia | Prevention or treatment of food allergy in infants and toddlers |
EP3193886A1 (en) * | 2014-09-15 | 2017-07-26 | N.V. Nutricia | Reducing anxiety in progeny |
WO2016046294A1 (en) * | 2014-09-25 | 2016-03-31 | Nestec S.A. | INFANT FORMULA SYSTEM WITH ADAPTIVE LEVELS OF HUMAN MILK OLIGOSACCHARIDES (HMOs) |
EP3223825A1 (en) * | 2014-11-26 | 2017-10-04 | Abbott Laboratories | Infant formula comprising human milk oligosaccharides, polyunsaturated fatty acids, nucleotides, and lutein |
US10500179B2 (en) | 2015-10-02 | 2019-12-10 | N. V. Nutricia | Glycine for use in tolerance induction in allergic patients |
US11432578B2 (en) * | 2015-12-15 | 2022-09-06 | Glycom A/S | Mixture of HMOs |
EP3443969B1 (en) * | 2016-04-13 | 2021-12-22 | Meiji Co., Ltd. | Use of bifidobacteria for improving developmental quotient in neonates |
AU2017275210B2 (en) * | 2016-05-31 | 2020-09-10 | Morinaga Milk Industry Co., Ltd. | Brain function improving agent |
MX2019000881A (en) * | 2016-07-28 | 2019-07-01 | Fonterra Cooperative Group Ltd | Dairy product and process. |
CN109963569A (en) * | 2016-10-05 | 2019-07-02 | 科尔生公司 | With based on amino acid alimentation composition fed infant or child in intestinal microbiota composition normalization |
US20200181654A1 (en) * | 2016-11-29 | 2020-06-11 | Morinaga Milk Industry Co., Ltd. | Aglycone production promoter |
WO2018143793A1 (en) * | 2017-02-01 | 2018-08-09 | N.V. Nutricia | Dietary modulation of brain functioning |
AU2018274637A1 (en) * | 2017-05-24 | 2019-09-26 | Societe Des Produits Nestle S.A. | Composition comprising oligofructose (OF) for use in the improvement of short term memory and other cognitive benefits |
US11026444B2 (en) | 2017-05-24 | 2021-06-08 | Societe Des Produits Nestle S.A. | Composition comprising human milk oligosaccharides (HMO) for use in the improvement of short term memory and other cognitive benefits |
CN110831608A (en) * | 2017-06-30 | 2020-02-21 | N·V·努特里奇亚 | Synbiotic composition for preventing disease |
WO2019068356A1 (en) * | 2017-10-06 | 2019-04-11 | N.V. Nutricia | Promoting cognitive function after birth by caesarean section |
CN111447936A (en) * | 2017-12-11 | 2020-07-24 | N·V·努特里奇亚 | Composition for treating delayed postnatal colonization of bifidobacteria |
US20210299193A1 (en) | 2018-07-13 | 2021-09-30 | Council Of Scientific & Industrial Research | Synbiotic composition for improving immune response and antioxidant capacity during aging and a process for the preparation thereof |
IT201900000043A1 (en) * | 2019-01-03 | 2020-07-03 | Watt S R L | Substitute for breakfast |
CN110214887B (en) * | 2019-06-28 | 2022-10-11 | 浙江大学 | Device and method for self-cooling type ultrahigh pressure sterilization of liquid |
JP7406325B2 (en) * | 2019-08-08 | 2023-12-27 | 森永乳業株式会社 | Composition for preventing or improving separation anxiety disorder |
GB2590624B (en) * | 2019-12-20 | 2023-08-30 | Green Bioactives Ltd | Composition comprising one or more fructooligosaccharide(s) and L-theanine |
EP3932415A1 (en) | 2020-07-01 | 2022-01-05 | Fundació Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta (IDIBGI) | Gut microbiota composition and uses thereof |
CN113025677A (en) * | 2021-03-12 | 2021-06-25 | 长春大学 | Method for preparing digestion-free sea cucumber protein by taking sea cucumber as raw material |
US20240358763A1 (en) * | 2021-06-02 | 2024-10-31 | N.V. Nutricia | Supplement for human milk from allergic women |
CN114533765B (en) * | 2022-03-17 | 2023-08-25 | 江南大学 | Application of Bifidobacterium breve CCFM1025 in regulating juvenile neurodevelopment |
GB2632345A (en) * | 2023-08-03 | 2025-02-05 | Mjn Us Holdings Llc | Human milk fortifier micronutrient supplementation kit |
WO2025027192A1 (en) * | 2023-08-03 | 2025-02-06 | Mjn U.S. Holdings Llc | Human milk fortifier micronutrient supplementation kit |
WO2025058081A1 (en) * | 2023-09-14 | 2025-03-20 | 江崎グリコ株式会社 | Composition for improving total attentiveness, cognitive flexibility, and/or execution function |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1065411C (en) * | 1995-06-18 | 2001-05-09 | 侯润安 | Healthful nutrition milk powder and production method |
DE19961535A1 (en) | 1999-12-20 | 2001-07-05 | Vacuumschmelze Gmbh | Filter arrangement |
NL1014380C2 (en) * | 2000-02-14 | 2001-08-15 | Friesland Brands Bv | Intestinal wall-strengthening food. |
FR2853908B1 (en) | 2003-04-16 | 2005-06-03 | Gervais Danone Sa | IMMUNOMODULATOR PRODUCT OBTAINED FROM CULTURE OF BIFIDOBACTERIUM AND COMPOSITIONS CONTAINING THE SAME |
CA2543626C (en) | 2003-10-24 | 2013-08-27 | N.V. Nutricia | Synbiotic composition for infants |
CN104223094A (en) * | 2005-02-28 | 2014-12-24 | 纽崔西亚公司 | Nutritional Composition With Probiotics |
EP1776877A1 (en) * | 2005-10-21 | 2007-04-25 | N.V. Nutricia | Method for stimulating the intestinal flora |
CN101795579A (en) * | 2006-08-04 | 2010-08-04 | Shs国际有限公司 | Protein free formula |
NL1033521C2 (en) * | 2007-03-08 | 2008-09-09 | Friesland Brands Bv | Children's foods with optimized amino acid composition. |
BRPI0721442A2 (en) | 2007-03-13 | 2013-01-15 | Nutricia Nv | use of a composition |
CN101636173A (en) * | 2007-03-27 | 2010-01-27 | 宝洁公司 | Methods and kits for administering probiotics |
WO2008153377A1 (en) * | 2007-06-15 | 2008-12-18 | N.V. Nutricia | Nutrition with non-viable bifidobacterium and non-digestible oligosaccharide |
AR072141A1 (en) * | 2008-06-13 | 2010-08-11 | Nutricia Nv | NUTRITIONAL COMPOSITION FOR CHILDREN BORN BY CESAREA |
US20120195935A1 (en) | 2009-07-27 | 2012-08-02 | Virginia Commonwealth University | Microbubble assisted viral delivery |
EP2308498A1 (en) | 2009-09-30 | 2011-04-13 | Nestec S.A. | Administration of Bifidobacterium breve during infancy to prevent inflammation later in life |
US20110086809A1 (en) | 2009-10-14 | 2011-04-14 | Joshua Anthony | Enteral Administration Of Arginine-Glutamine Dipeptide To Support Retinal, Intestinal, Or Nervous System Development |
CN102724886A (en) | 2009-10-29 | 2012-10-10 | 雀巢产品技术援助有限公司 | Nutritional compositions comprising lactoferrin and probiotics and kits of parts thereof |
EP2335502A1 (en) * | 2009-12-07 | 2011-06-22 | Nestec S.A. | An infant formula delivery system comprising probiotics and an infant nutritional formulation |
US20110208153A1 (en) | 2010-02-24 | 2011-08-25 | John Alvey | Formulations and methods for nutrient delivery |
SG191393A1 (en) * | 2010-12-31 | 2013-08-30 | Abbott Lab | Neutral human milk oligosaccharides to promote growth of beneficial bacteria |
US20130095204A1 (en) * | 2011-10-14 | 2013-04-18 | Zeina Jouni | Nutritional phytonutrient compositions |
US20140357571A1 (en) | 2012-01-09 | 2014-12-04 | N.V. Nutricia | Glutamine enriched nutritional composition for preterm infants |
-
2013
- 2013-11-04 CN CN201711281376.4A patent/CN107853705A/en active Pending
- 2013-11-04 MY MYPI2015001127A patent/MY173726A/en unknown
- 2013-11-04 PH PH1/2015/500904A patent/PH12015500904B1/en unknown
- 2013-11-04 AU AU2013338705A patent/AU2013338705B2/en active Active
- 2013-11-04 CN CN201380069118.3A patent/CN104883908A/en active Pending
- 2013-11-04 EP EP21175733.1A patent/EP3936134A1/en active Pending
- 2013-11-04 BR BR112015009579A patent/BR112015009579B1/en active IP Right Grant
- 2013-11-04 RU RU2015120800A patent/RU2630905C2/en active
- 2013-11-04 EP EP13795882.3A patent/EP2914136B1/en active Active
- 2013-11-04 ES ES13795882T patent/ES2884223T3/en active Active
- 2013-11-04 WO PCT/NL2013/050785 patent/WO2014070016A2/en active Application Filing
- 2013-11-04 US US14/440,299 patent/US9974816B2/en active Active
- 2013-11-04 IN IN3862DEN2015 patent/IN2015DN03862A/en unknown
- 2013-11-04 PL PL13795882T patent/PL2914136T3/en unknown
-
2018
- 2018-05-02 US US15/969,401 patent/US20190076490A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
PL2914136T3 (en) | 2021-11-29 |
ES2884223T3 (en) | 2021-12-10 |
US20150366919A1 (en) | 2015-12-24 |
EP2914136B1 (en) | 2021-05-26 |
WO2014070016A2 (en) | 2014-05-08 |
BR112015009579B1 (en) | 2020-04-28 |
CN104883908A (en) | 2015-09-02 |
PH12015500904A1 (en) | 2015-07-13 |
AU2013338705A1 (en) | 2015-06-04 |
BR112015009579A2 (en) | 2017-07-04 |
RU2015120800A (en) | 2016-12-27 |
US9974816B2 (en) | 2018-05-22 |
AU2013338705A2 (en) | 2015-06-04 |
EP2914136A2 (en) | 2015-09-09 |
PH12015500904B1 (en) | 2023-04-19 |
MY173726A (en) | 2020-02-18 |
CN107853705A (en) | 2018-03-30 |
RU2630905C2 (en) | 2017-09-14 |
EP3936134A1 (en) | 2022-01-12 |
WO2014070016A3 (en) | 2014-06-26 |
US20190076490A1 (en) | 2019-03-14 |
AU2013338705B2 (en) | 2017-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IN2015DN03862A (en) | ||
TR201902529T4 (en) | Nutritional composition that affects immunity. | |
CA140214S (en) | Infant bodysuit | |
ZA201409369B (en) | Composition comprising probiotic bacteria for the treatment of pathologies associated with alterations of the immune system | |
PL2900805T3 (en) | Probiotic and prebiotic compositions | |
AU349004S (en) | Infant feeding bowl | |
ZA201505201B (en) | Bacterial cellulose and bacterium producing same | |
PL2707478T3 (en) | Probiotic bacterial strains and symbiotic composition containing the same intended for infant food | |
RS55221B1 (en) | Fermented infant formula with non digestible oligosaccharides | |
GB201206599D0 (en) | Probiotic bacteria | |
PT3068404T (en) | Compositions for use in the prevention or treatment of urt infections in infants or young children at risk | |
PT3366143T (en) | Probiotic compositions and methods | |
PL2898002T3 (en) | Production of blend of polyolefin and organopolysiloxane | |
EP3033351A4 (en) | Antiviral methods and compositions comprising probiotic bacterial molecules | |
EP3082450A4 (en) | Pet food composition having probiotic bifidobacterium animalis | |
IL243927A0 (en) | Digestive enzyme composition suitable for enteral administration | |
CA144994S (en) | Pillow | |
EP2914638A4 (en) | Propylene copolymer compositions and processes to produce them | |
PH12015501334A1 (en) | Milk-based nutritional compositions containing lactoferrin and uses thereof | |
PH12014500185A1 (en) | Galactooligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract | |
CA144993S (en) | Pillow | |
BR112012023328A2 (en) | nutritional compositions | |
SG11201504542PA (en) | Probiotic strains for the treatment and/or prevention of diarrhœa | |
NZ626540A (en) | Glutamine enriched nutritional composition for preterm infants | |
PH12014501569A1 (en) | Glutamine enriched nutritional composition for preterm infants |